VECTUS BIOSYSTEMS LIMITED — Share Issue/Capital Change 2025

Mar 11, 2025

==> picture [513 x 94] intentionally omitted <==

12 March 2025

Company Announcements Office Australian Securities Exchange

ISSUE OF SHARES

Vectus Biosystems Limited (ASX:VBS) (Vectus or the Company) advises that today it issued 25,000 new fully paid ordinary shares. The shares were allotted on the exercise of options (after vesting), issued under the Employee Incentive Plan, by two of the Company’s contractors. The Appendix 2A was released to the market today and below is a Cleansing Notice for the issue of these shares.

Cleansing Notice Under Section 708A(5)(e)

Vectus advises that on 12 March 2025 the Company issued 25,000 new fully paid ordinary shares, as set out above. Vectus also advises that:

• (1) this notice is being given within five business days after the day of the issue under section 708A(5)(e) of the Corporations Act 2001 (Cth);

• (2) the Company issued the securities without disclosure to investors under Part 6D.2 of the Corporations Act 2001;

• (3) as at the date of this notice, Vectus has complied with:

  • (a) the provisions of Chapter 2M of the Corporations Act 2001 as they apply to the Company; and

• (b) section 674 of the Corporations Act 2001; and

• (4) except as may be set out in this notice, there is no other information that is excluded information as at the date of this notice that is required to be set out in this notice under section 708A(6)(e) of the Corporations Act 2001.

Vectus Biosystems Limited

Robert J Waring

Company Secretary

This announcement was authorised by the Company’s Disclosure Committee.

VECTUS BIOSYSTEMS LIMITED ABN 54 117 526 137

Ground Floor, Unit 5, 26-34 Dunning Avenue, Rosebery NSW 2018 Australia Telephone: +61 2 8344 1300, Facsimile: +61 2 9697 0944 Email: info@vectusbiosystems.com.au Website: www.vectusbiosystems.com.au